Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Multiple sklerose
by Highest Patent Value in the China in 2019

The Multiple sklerose top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Multiple sklerose Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 5.25 M
2
Drug,Health care,Antineoplastic Drugs,
...[+2]
Avg patent value: 3.54 M
3
Pharmacy and Therapeutics,Clinical trial,Biopharmaceutical,
...[+2]
Avg patent value: 3.17 M
4
Avg patent value: 3.17 M
5
Shanghai Theorion Pharmaceutical Co., Ltd.
Avg patent value: 3.13 M
6
Avg patent value: 2.70 M
7
Avg patent value: 2.63 M
8
Avg patent value: 1.91 M
9
Avg patent value: 220,000
10
Avg patent value: 220,000
11
Avg patent value: 85,000
12
I-mab Biopharma(Hangzhou) Co., Ltd.
Avg patent value: 81,000
13
TransThera Biosciences
Open innovation,Biology
Avg patent value: 73,000
14
TransThera Sciences (Nanjing), Inc.
Avg patent value: 73,000
15
Avg patent value: 70,000
16
Avg patent value: 67,000
17
1globe Biomedical Co Ltd
Avg patent value: 21,000
18
Avg patent value: 18,000
19
Avg patent value: 16,000
20
Avg patent value: 3,600
Page generation time: Jul 23 2025